Call Options

21 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$64.76 - $79.84 $278,468 - $343,312
-4,300 Reduced 59.72%
2,900 $198,000
Q1 2024

May 15, 2024

BUY
$64.37 - $75.65 $450,590 - $529,550
7,000 Added 3500.0%
7,200 $498,000
Q4 2023

Feb 14, 2024

BUY
$46.37 - $73.65 $9,274 - $14,730
200 New
200 $14,000
Q1 2023

May 15, 2023

SELL
$43.8 - $56.99 $1.45 Million - $1.89 Million
-33,100 Reduced 78.44%
9,100 $492,000
Q4 2022

Feb 14, 2023

SELL
$44.07 - $54.45 $599,352 - $740,520
-13,600 Reduced 24.37%
42,200 $2.23 Million
Q3 2022

Nov 14, 2022

BUY
$42.7 - $59.99 $1.99 Million - $2.8 Million
46,600 Added 506.52%
55,800 $2.6 Million
Q2 2022

Aug 08, 2022

SELL
$43.0 - $65.64 $180,600 - $275,688
-4,200 Reduced 31.34%
9,200 $525,000
Q1 2022

May 16, 2022

SELL
$38.74 - $62.09 $581,100 - $931,350
-15,000 Reduced 52.82%
13,400 $820,000
Q4 2021

Feb 14, 2022

SELL
$35.2 - $53.42 $109,120 - $165,602
-3,100 Reduced 9.84%
28,400 $1.49 Million
Q3 2021

Nov 15, 2021

SELL
$28.72 - $42.49 $2.88 Million - $4.26 Million
-100,300 Reduced 76.1%
31,500 $1.17 Million
Q2 2021

Aug 16, 2021

BUY
$29.3 - $44.5 $3.56 Million - $5.41 Million
121,600 Added 1192.16%
131,800 $5.38 Million
Q1 2021

May 17, 2021

SELL
$30.8 - $39.51 $471,240 - $604,503
-15,300 Reduced 60.0%
10,200 $346,000
Q4 2020

Feb 16, 2021

SELL
$23.34 - $32.22 $665,190 - $918,270
-28,500 Reduced 52.78%
25,500 $811,000
Q3 2020

Nov 16, 2020

BUY
$17.61 - $31.86 $950,940 - $1.72 Million
54,000 New
54,000 $1.39 Million
Q2 2020

Aug 14, 2020

SELL
$14.35 - $26.64 $7,175 - $13,320
-500 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$12.31 - $33.12 $137,872 - $370,944
-11,200 Reduced 95.73%
500 $8,000
Q4 2019

Feb 14, 2020

SELL
$7.26 - $38.49 $176,418 - $935,307
-24,300 Reduced 67.5%
11,700 $401,000
Q3 2019

Nov 14, 2019

BUY
$7.47 - $14.03 $268,173 - $503,677
35,900 Added 35900.0%
36,000 $269,000
Q2 2019

Aug 14, 2019

SELL
$10.65 - $14.29 $226,845 - $304,377
-21,300 Reduced 99.53%
100 $1,000
Q1 2019

May 15, 2019

BUY
$10.9 - $14.09 $202,740 - $262,074
18,600 Added 664.29%
21,400 $261,000
Q4 2018

Feb 14, 2019

BUY
$10.36 - $20.96 $29,008 - $58,688
2,800 New
2,800 $32,000

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.07B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.